from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1384/carB

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

0.000

Cap5-10ug/mL Capreomycintranslation

2.217

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.605

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.285

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.440

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.261

CPZ10-50 ug/mL Chlorpromazinerespiration

0.144

Clofazimine10-13 ug/mL Clofaziminerespiration

0.070

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.960

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.124

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.098

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.324

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.287

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.054

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.115

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.121

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.626

KCN5-20 ug/mL Potassium cyaniderespiration

-0.459

NaN30.2-2 mM Sodium aziderespiration

-0.476

Nigericin50 uM Nigericinrespiration

0.012

TRC10-150 ug/mL Triclosanrespiration

0.114

TRZ10-25 ug/mL Thioridazinerespiration

-0.984

Valinomycin0.5-10 uM Valinomycinrespiration

-0.886

ZnSO42 mM ZnSO4respiration

-0.142

menadione6-10 ug/mL Menadionerespiration

-1.253

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.792

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

3.401

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.540

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.328

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

-0.007

Cephalexin20-100 ug/mL CephalexincellWall

0.520

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.993

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.305

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.445

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.230

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.257

BZA0.12 mg/mL BenzamidearomaticAmides

-0.059

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.491

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.680

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.792

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.390

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.379

UVUV-irradiationDNAdamaging

0.944

ARP41-4 ug/mL Antitubercular compound ARP4?

1.067

Antimycin12.5-50 ug/mL Antimycin A?

0.335

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.005

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.224

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.623

PA8240.2-2 ug/mL PA-824?

0.068

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.430

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.463

Verapamil50 uM Verapamil?

0.447

mercaptoethanol2 mM 2-Mercaptoethanol?

0.203

methoxatin10-20 ug/mL Methoxatin?